Retatrutide

Retatrutide is a research compound studied for metabolic and weight-management pathways. It is known as a triple-receptor agonist because it targets GLP-1, GIP, and glucagon receptors. These pathways are heavily studied for their roles in appetite signalling, glucose control, energy use, and body-weight regulation. Clinical research has studied retatrutide in obesity and metabolic disease models.